BAK Valuation

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

BAK Relative Valuation

BAK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BAK is overvalued; if below, it's undervalued.

Historical Valuation

Braskem SA (BAK) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.10 is considered Undervalued compared with the five-year average of 0.27. The fair price of Braskem SA (BAK) is between 15.52 to 21.76 according to relative valuation methord. Compared to the current price of 3.95 USD , Braskem SA is Undervalued By 74.55%.

Relative Value

Fair Zone

15.52-21.76

Current Price：3.95

74.55%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

-3.75

P/B

Median3y

-74.23

Median5y

-40.94

-14.46

FCF Yield

Median3y

-4.35

Median5y

2.85

Competitors Valuation Multiple

The average P/S ratio for BAK's competitors is 1.16, providing a benchmark for relative valuation. Braskem SA Corp (BAK) exhibits a P/S ratio of 0.10, which is -91.12% above the industry average. Given its robust revenue growth of 12.26%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap